Opioid maintenance treatment of pregnant women in the Scandinavian countries

Show full item record




Handal , M , Skurtveit , S , Mahic , M , Øhman , I , Wikner , B N , Tjagvad , C , Kieler , H , Halmesmäki , E & Lund , I O 2020 , ' Opioid maintenance treatment of pregnant women in the Scandinavian countries ' , Nordisk alkohol- & narkotikatidskrift , vol. 37 , no. 3 , pp. 298-312 . https://doi.org/10.1177/1455072520914114

Title: Opioid maintenance treatment of pregnant women in the Scandinavian countries
Author: Handal, Marte; Skurtveit, Svetlana; Mahic, Milada; Øhman, Inger; Wikner, Birgitta Norstedt; Tjagvad, Christian; Kieler, Helle; Halmesmäki, Erja; Lund, Ingunn Olea
Contributor organization: HUS Gynecology and Obstetrics
Department of Obstetrics and Gynecology
University of Helsinki
Date: 2020-06
Language: eng
Number of pages: 15
Belongs to series: Nordisk alkohol- & narkotikatidskrift
ISSN: 1455-0725
DOI: https://doi.org/10.1177/1455072520914114
URI: http://hdl.handle.net/10138/326529
Abstract: Background: WHO guidelines emphasise the need for descriptions of clinical practice and observational studies on risk and benefits of pharmacotherapies in pregnancy. The aims of the present study were to: (1) Describe opioid maintenance treatment (OMT) in the Scandinavian countries in general, and specifically for pregnant women, (2) Describe a project which utilises a new approach using registry-linkage data to examine associations between prenatal exposure to OMT and child outcomes: a Scandinavian cohort study of pregnant women in OMT during pregnancy (ScopeOMT). Data: Guidelines describing the treatment of persons with opioid use disorders in general, and specifically for pregnant women. Scandinavian registry-linkage data from ScopeOMT. Results: Registry data show that approximately 800 pregnant women received OMT during pregnancy in the period of the ScopeOMT study. Similarities across the Scandinavian countries include access to free healthcare and treatment; multidisciplinary teams trained to support pregnant women in OMT; buprenorphine as the recommended drug when initiating therapy; and a holistic focus on the patients' lives. An important difference is that Norwegian women who use illegal substances that may harm the foetus may be admitted - voluntarily, or against their will - for parts of, or the remainder of the pregnancy to inpatient treatment at specialised clinics. Conclusion: Many similarities in the treatment provided to opioid-dependent persons in the Scandinavian countries place this area in an excellent position to combine the efforts and carry out observational studies concerning the safety of OMT during pregnancy.
Subject: buprenorphine
opioid maintenance treatment
3123 Gynaecology and paediatrics
Peer reviewed: Yes
Rights: cc_by_nc
Usage restriction: openAccess
Self-archived version: publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
1455072520914114.pdf 281.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record